Share this article
Share this article
PLANO, Texas, June 9, 2021 /PRNewswire/ U.S. Renal Care (USRC), a leading provider of dialysis services, announced it has completed administering the second round of mRNA vaccines to patients, ensuring better protection against the deadly coronavirus for thousands of vulnerable patients on dialysis.
Journal of the American Society of Nephrology, demonstrated that patients are more likely to consent to the COVID-19 vaccine if it was provided by their dialysis center. The study was authored, in part, by USRC physician leaders, Mary Dittrich, MD, FASN and Chief Medical Officer of USRC and Geoff Block, MD, Associate Chief Medical Officer & SVP, Clinical Research & Medical Affairs for USRC.